Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1997-08-05
2000-04-04
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241431, 4241441, 4241451, 4241531, 53038822, 53038823, 53038873, 53038875, A61K 39395
Patent
active
060457953
ABSTRACT:
The present invention concerns a method of treating sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CDl4 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
REFERENCES:
patent: 4834976 (1989-05-01), Rosol et al.
patent: 4918163 (1990-04-01), Young et al.
patent: 5057598 (1991-10-01), Pollack et al.
patent: 5730980 (1998-03-01), Ulevitch et al.
Ashmun, et al., Blood, 69:886-892 (1987).
Bazil, et al., "Eur. J. Immunol.", 16:1583-1589 (1986).
Beutler, et al., "Science", 229:869 (1985).
Beutler, et al., "N. Eng. J. Med.", 316:379 (1987).
Ehlenberger, et al., "J. Exp. Med.", 145:357-371 (1977).
Espevik, et al., "J. Immunol. Meth.", 95:99-105 (1986).
Ferrero, et al., "Nucleic Acids Research", vol. 16:4173 (1988).
Goyert, et al., "Science", 239:497-500 (1988).
Mathison, et al., "J. Clin. Invest.", 81:1925 (1988).
Michie, et al., "New Eng. J. Med.", 318:1481-1486 (1988).
Tobias, et al., "J. Exp. Med.", 164:777-793 (1986).
Tobias, et al., "J. Biol. Chem.", 263:13749-13481 (1988).
Tobias, et al., "J. Biol. Chem.", 264:10867-10871 (1989).
Tracey, et al., "Nature", 330:662-664 (19870.
Van Deventer, et al., "Lancet", 1:605-608 (1988).
Van Voorhis, et al., "J. Exp. Med.", 158:126-145, (1983).
Waage, et al., "Lancet", 1:355-357 (1987).
Wright, et al., "J. Exp. Med.", 156:1149-1164 (1982).
Wright, et al., "J. Exp. Med.", 158:1338-1343.
Wright, et al., "Proc. Natl. Acad. Sci. USA", 80:5699-5703 (1983).
Wright, et al., "L. Exp. Med.", 164:1876-1888 (1986).
Greisham, et al., Experimental Gram NG. Bacterial Sepsis Prevention of Mortality not preventable by antiobiotics alone.
Tracey, et al., "Anti-cacheclin/TNF monoclonial antibodies prevent septic shock during lethal bacteralmia".
Spalding, Bio ?Technology, "In Shockery Synergey Sepsis tallies third victim" 428-429 (Apr. 1993.
Gibbs, Scientific American, "Try, Try Again making antibodies more useful by making them more human" 101-103 (Jul. 1993).
Hinshaw, et al., "Surg. Gynecol and Obstetrics" 145:1-11, 1977.
Hess, et al., "Surg. Gynecol. & Obstetrics" 166:147-153 1988.
Cross, et al., "Infection and Immunity" 61:2741-2747 1993.
Fink, et al., "Journal of Surg. Res."49:186-196 1990.
Schuett, et al., "Immunology Lett." 19:321-328 1988.
Oden, et al., "Develop Biol. Standard" 24:181-187, 1974.
Speigers, et al., "Vaccine" 7:364-368, 1984.
Cross, et al., "The Journal of Endotoxin Research" pp. 57-69, 1994.
Bogman, et al., "Diagnosis of Renal Allograft Rejection by Macrophage Immunostaining with a CD14 Monoclonal Antibody, WT14", The Lancet, 235-238, 1989.
Schutt et al., Immunol. Letters 19:32-328, 1988.
Mathison John C.
Tobias Peter
Ulevitch Richard
Wright Samuel D.
Budens Robert D.
Haile Lisa A.
The Scripps Research Institute
LandOfFree
Methods and compositions for ameliorating the symptoms of sepsis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for ameliorating the symptoms of sepsis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for ameliorating the symptoms of sepsis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-362259